Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment

By Vehmanen L.   Saarto T.   Elomaa I.   Makela P.   Valimaki M.   Blomqvist C.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2373-2378

Elsevier

Access to resources Recommend Favorite

Short‐Term Intermittent Intravenous Clodronate in the Prevention of Bone Loss Related to Chemotherapy‐Induced Ovarian Failure

By Vehmanen Leena  

Breast Cancer Research and Treatment, Vol. 87, Iss. 2, 2004-09 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite

Serum selenium measurements in women with early-stage breast cancer with and without chemotherapy-induced ovarian failure

By Breedlove Hollie   Smith Anne   Burk Raymond   Hill Kristina   Shapiro Charles  

Breast Cancer Research and Treatment, Vol. 97, Iss. 3, 2006-06 ,pp. : 225-230

Springer Publishing Company

Access to resources Recommend Favorite

Bcl-x L Is Expressed in Ovarian Carcinoma and Modulates Chemotherapy-Induced Apoptosis

By Liu J.R.   Fletcher B.   Page C.   Hu C.   Nunez G.   Baker V.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 398-403

Elsevier

Access to resources Recommend Favorite

Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?

By Cameron David   Douglas Sharon   Brown Janet   Anderson Richard  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 805-814

Springer Publishing Company

Access to resources Recommend Favorite